Hospital
Bladen Healthcare LLC
Bladen Healthcare LLC was paid $7.78M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoBLADEN HEALTHCARE LLC
ELIZABETHTOWN, NC 28337
ELIZABETHTOWN, NC 28337
33aNPI1558537282assigned 05/02/2008
33bProvider typeCritical Access Hospital
28Total paid$7.78M
24GClaims158,532
24DCodes billed81
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in North Carolina
Rank by total paid#2 of 25
Median peer was paid$1.32M
This provider vs. median5.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FISER, JOSEPH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,921 | $886K | |
| 2019 | 26,332 | $853K | |
| 2020 | 15,199 | $540K | |
| 2021 | 15,238 | $780K | |
| 2022 | 22,195 | $1.27M | |
| 2023 | 25,818 | $1.41M | |
| 2024incomplete | 30,829 | $2.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 17,064 | 14,754 | $2.82M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 16% | 8,558 | 7,548 | $1.22M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 4,982 | 4,236 | $1.12M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 13% | 10,293 | 8,847 | $1.04M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.9% | 2,711 | 2,256 | $229K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 6,252 | 4,860 | $197K |
| 71045 | Radiologic examination, chest; single view | 1.9% | 4,053 | 3,584 | $146K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 379 | 316 | $131K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 5,760 | 5,469 | $94K |
| J3490 | Unclassified drugs | <1% | 17,468 | 8,576 | $73K |
| 80053 | Comprehensive metabolic panel | <1% | 11,199 | 9,242 | $65K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,604 | 1,523 | $65K |
69 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,580 | $44K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,919 | $42K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 303 | $42K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 787 | $41K |
| 85027 | <1% | 8,537 | $36K | |
| 87070 | <1% | 3,640 | $35K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 151 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,897 | $23K |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,591 | $21K |
| 84484 | <1% | 3,314 | $19K | |
| 87400 | <1% | 1,563 | $19K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 478 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 382 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 316 | $16K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $15K |
| 81001 | <1% | 5,883 | $15K | |
| A9270 | Non-covered item or service | <1% | 8,558 | $14K |
| 76801 | <1% | 66 | $13K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,111 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 69 | $7K |
| 81025 | <1% | 1,008 | $7K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 960 | $6K |
| 83735 | <1% | 1,370 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 235 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 140 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 85 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 222 | $5K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 206 | $5K |
| 83690 | <1% | 819 | $5K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 45 | $4K |
| 87807 | <1% | 287 | $4K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 24 | $4K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 316 | $4K |
| 87088 | <1% | 484 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 15 | $3K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,216 | $3K |
| 0012A | <1% | 51 | $2K | |
| 0011A | <1% | 63 | $2K | |
| 80061 | Lipid panel | <1% | 153 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 69 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 406 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $2K |
| 81003 | <1% | 523 | $1K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 56 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 68 | $1K |
| 82947 | <1% | 289 | $963.92 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 158 | $636.20 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 72 | $616.59 |
| 82550 | <1% | 271 | $593.79 | |
| 85730 | <1% | 212 | $552.17 | |
| 83605 | <1% | 94 | $542.56 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 14 | $494.40 |
| 86900 | <1% | 163 | $465.16 | |
| 86901 | <1% | 163 | $461.45 | |
| J2704 | Injection, propofol, 10 mg | <1% | 35 | $458.13 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $442.68 |
| 84100 | <1% | 226 | $430.26 | |
| 86592 | <1% | 88 | $352.56 | |
| 85610 | <1% | 212 | $337.07 | |
| 84439 | <1% | 26 | $228.25 | |
| 86850 | <1% | 15 | $198.12 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 36 | $168.69 |
| 94664 | <1% | 13 | $163.34 | |
| 87340 | <1% | 13 | $139.08 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $130.65 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 24 | $121.33 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $90.55 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 28 | $81.37 |
| 85018 | <1% | 25 | $56.24 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFISER, JOSEPH (VP CORP REVENUE CYCLE/MANAGED CARE)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.